These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9725812)

  • 1. Impaired phasic insulin and amylin secretion in diabetic rats.
    Leahy JL; Fineman MS
    Am J Physiol; 1998 Sep; 275(3):E457-62. PubMed ID: 9725812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parallel reduction of pancreas insulin content and insulin secretion in 48-h tolbutamide-infused normoglycemic rats.
    Hosokawa YA; Leahy JL
    Diabetes; 1997 May; 46(5):808-13. PubMed ID: 9133548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-secretion of amylin and insulin from cultured islet beta-cells: modulation by nutrient secretagogues, islet hormones and hypoglycemic agents.
    Moore CX; Cooper GJ
    Biochem Biophys Res Commun; 1991 Aug; 179(1):1-9. PubMed ID: 1679326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative hypersecretion of amylin to insulin from rat pancreas after neonatal STZ treatment.
    Inoue K; Hisatomi A; Umeda F; Nawata H
    Diabetes; 1992 Jun; 41(6):723-7. PubMed ID: 1534057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diazoxide causes recovery of beta-cell glucose responsiveness in 90% pancreatectomized diabetic rats.
    Leahy JL; Bumbalo LM; Chen C
    Diabetes; 1994 Feb; 43(2):173-9. PubMed ID: 8288040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of impaired glucose-potentiated insulin secretion in diabetic 90% pancreatectomy rats. Study using glucagonlike peptide-1 (7-37).
    Hosokawa YA; Hosokawa H; Chen C; Leahy JL
    J Clin Invest; 1996 Jan; 97(1):180-6. PubMed ID: 8550831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amylin secretion from the perfused pancreas: dissociation from insulin and abnormal elevation in insulin-resistant diabetic rats.
    Gedulin B; Cooper GJ; Young AA
    Biochem Biophys Res Commun; 1991 Oct; 180(2):782-9. PubMed ID: 1953751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Release of amylin from perfused rat pancreas in response to glucose, arginine, beta-hydroxybutyrate, and gliclazide.
    Inoue K; Hisatomi A; Umeda F; Nawata H
    Diabetes; 1991 Aug; 40(8):1005-9. PubMed ID: 1860552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of amylin on the release of insulin and glucagon from the perfused rat pancreas.
    Inoue K; Hiramatsu S; Hisatomi A; Umeda F; Nawata H
    Horm Metab Res; 1993 Mar; 25(3):135-7. PubMed ID: 8477949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal glucose regulation of insulin secretion in models of reduced B-cell mass.
    Leahy JL; Bonner-Weir S; Weir GC
    Diabetes; 1984 Jul; 33(7):667-73. PubMed ID: 6203798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effect of amylin (islet amyloid polypeptide) on insulin response to non-glucose stimuli. Study in perfused rat pancreas.
    Salas M; Silvestre RA; Garcia-Hermida O; Fontela T; Rodriguez-Gallardo J; Marco J
    Diabete Metab; 1995 Oct; 21(4):269-73. PubMed ID: 8529762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-cell dysfunction in hyperglycaemic rat models: recovery of glucose-induced insulin secretion with lowering of the ambient glucose level.
    Leahy JL; Weir GC
    Diabetologia; 1991 Sep; 34(9):640-7. PubMed ID: 1955096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Disparity between the effect of glucose and arginine on insulin secretion from the perfused pancreas of non insulin dependent diabetic rats].
    Giroix MH; Portha B; Kergoat M; Picon L
    C R Seances Acad Sci III; 1981 Nov; 293(10):601-6. PubMed ID: 6800578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of effect of CS-045, a new antidiabetic agent, on insulin secretion in the remnant pancreas after 90% pancreatectomy in rats.
    Inoue Y; Tanigawa K; Nakamura S; Xu G; Kawaguchi M; Kato Y; Tamura K
    Diabetes Res Clin Pract; 1995 Jan; 27(1):19-26. PubMed ID: 7781490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of tolbutamide on insulin, glucagon, and somatostatin release from the diabetic rat pancreas with special reference to glucose concentration.
    Kadowaki S; Taminato T; Chiba T; Nozawa M; Fujita T; Norman AW
    Endocrinology; 1983 Jun; 112(6):2187-92. PubMed ID: 6133743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central visfatin potentiates glucose-stimulated insulin secretion and β-cell mass without increasing serum visfatin levels in diabetic rats.
    Kim DS; Kang S; Moon NR; Park S
    Cytokine; 2014 Feb; 65(2):159-66. PubMed ID: 24332931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulated hexokinase activity in isolated islets from diabetic 90% pancreatectomized rats.
    Hosokawa H; Hosokawa YA; Leahy JL
    Diabetes; 1995 Nov; 44(11):1328-33. PubMed ID: 7589832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alteration of beta-cell constitutive NO synthase activity is involved in the abnormal insulin response to arginine in a new rat model of type 2 diabetes.
    Novelli M; Pocai A; Lajoix AD; Beffy P; Bezzi D; Marchetti P; Gross R; Masiello P
    Mol Cell Endocrinol; 2004 Apr; 219(1-2):77-82. PubMed ID: 15149729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amylin tonally regulates arginine-stimulated insulin secretion in rats.
    Bennet WM; Beis CS; Ghatei MA; Byfield PG; Bloom SR
    Diabetologia; 1994 Apr; 37(4):436-8. PubMed ID: 8063047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. beta-cell adaptation in 60% pancreatectomy rats that preserves normoinsulinemia and normoglycemia.
    Liu YQ; Nevin PW; Leahy JL
    Am J Physiol Endocrinol Metab; 2000 Jul; 279(1):E68-73. PubMed ID: 10893324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.